Consensus Cameco Corporation

Equities

CCO

CA13321L1085

Market Closed - Toronto S.E. 04:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
66.34 CAD -0.49% Intraday chart for Cameco Corporation -3.90% +16.12%

Evolution of the average Target Price on Cameco Corporation

Price target over the last 5 years

History of analyst recommendation changes

b32d8d90d.KAsd6XPG-oNd-SdyPA9CZv2EKv-o-_xP0mx9vvhhI6w.GVh3ujiNu9YJyxc3T0AIFLTzGZvaq5cFpjktj40MYZpgWWu7HfeK6w-6QA~a6c94c9fd69ad5053616ffa582e9f881
Cameco Shares Rise After Goldman Sachs Initiates Coverage at Buy MT
Goldman Sachs Initiates Cameco With Buy Rating, $55 Price Target MT
The market faces a choice Our Logo
ANALYST RECOMMENDATIONS : Biogen, Gsk, Hp Inc, Palantir, Walt Disney... Our Logo
Cameco Maintained at Outperform at RBC Following Q4 Results; Price Target Kept at C$70.00 MT
Cameco Maintained at Outperform at BMO Ahead of Q4 Results; Price Target Kept at C$72.00 MT
Cameco Maintained at Outperform at BMO Following Investor Day; Price Target Raised to C$72.00 MT
Cameco Price Target Raised to $68.50 at CIBC MT
Cameco Maintained at Outperform at BMO as Westinghouse Acquisition Closes; Price Target at C$68.00 MT
Fed Rate Outlook, Earnings Lift Exchange-Traded Funds, Equity Futures Pre-Bell Monday MT
BofA Securities Adjusts Price Target on Cameco to $46 From $44.50, Maintains Buy Rating MT
DBRS Confirms Cameco Ratings; Removes Ratings From Under Review With Developing Implications MT
Cameco Price Target Raised to $70 at TD MT
Cameco Declines More Than 2% Following Update, TD Maintains Outlook on Stock MT
ANALYST RECOMMENDATIONS : American Express, Biogen, Tesco, Eli Lilly, Oracle... Our Logo
TSX Brief: Celestica Reported 13% Revs Growth In Most Recent Quarter, Raised FY Forecasts In Late July, Got Two Analyst Upgrades in Late July and Is Rated 'Buy' By Six of Seven Analysts, notes BNN Bloomberg TV MT
Cameco Price Target Raised to $55 at TD MT
Toronto Stocks Drop Amid U.S. Credit-Rating Downgrade; Cameco Shares Down DJ
Cameco Brief: Says Gross Profit benefitting from transition to tier-one run rate; FY Revenue outlook increased driven by improving market fundamentals; Uranium market Moving toward replacement-rate contracting MT
Cameo Price Target Raised to $50 at Raymond James MT
Cameco Upgraded to Action List Buy at TD MT
Cameco Price Target Lowered to $44 at Raymond James, Maintains Outperform Rating MT
Cameco Price Target Lowered to $40 at TD Following Westinghouse Deal MT
TSX set to snap four-day losing streak, U.S. data in focus RE
Cameco Rises 5% After Filing Prospectus, TD Maintains Buy rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
66.67 CAD
Average target price
74.76 CAD
Spread / Average Target
+12.14%
High Price Target
80 CAD
Spread / Highest target
+19.99%
Low Price Target
65 CAD
Spread / Lowest Target
-2.50%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Cameco Corporation

Goldman Sachs
RBC Capital Markets
BMO Capital
CIBC World Markets
BofA Securities
TD Securities
Raymond James
Scotiabank
Cantor Fitzgerald
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
  1. Stock Market
  2. Equities
  3. CCO Stock
  4. Consensus Cameco Corporation